每经记者 叶峰 每经编辑 肖芮冬 港股创新药概念股走强，信达生物涨超7%，康方生物涨超6%，三生制药涨超4%。受盘面影响，多只港股创新药相关ETF涨超3%。有券商表示，完善创新药价格机制、构建多元化的支付体系，创新药的国内政策环境持续向好，同时海外临床数据陆续发布，对外授权进入高峰期，创新价值兑现加速，维持医药行业“推荐”的评级。 海量资讯、精准解读，尽在新浪...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.